Finerenone for early menopause in women under 40
Treatments studied
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests a medicine called finerenone to see if it can help women with premature ovarian insufficiency (early menopause). It may help restore ovarian function and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman under 40 years old.
- You have been diagnosed with premature ovarian insufficiency (early menopause).
- You have gone at least 4 months without a period or with very irregular periods.
- A blood test shows your FSH (follicle-stimulating hormone) level is 25 or higher.
- You do not have severe, uncontrolled health conditions (like heart, liver, kidney, or hormone problems).
- You have never had cancer (especially a hormone-related cancer) and are not in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows women with premature ovarian insufficiency (POI) over time to understand how it affects their health. Researchers will collect samples and track health changes to learn more about the condition and its long-term effects.
This trial tests whether a hormone injection called HCG can activate dormant egg follicles in women under 40 who have gone through premature ovarian insufficiency (POI). If successful, it may help these women conceive.
This trial tests whether hormone replacement therapy (HRT) helps protect bone health in teenagers with premature ovarian insufficiency (POI). It compares HRT to a placebo and also includes healthy volunteers for comparison.
This study tests a Chinese herbal medicine called Huanjingjian Decoction to see if it helps women with premature ovarian insufficiency (early menopause) have more regular periods and improve hormone levels. If you are under 40 and have this condition, this treatment might help you.
This trial tests whether a single infusion of stem cells made from human umbilical cord tissue can help women with premature ovarian insufficiency (early menopause) by improving ovarian function and reducing menopause symptoms. Participants will continue their usual hormone replacement therapy during the study.
This study looks at the genes that may cause premature ovarian insufficiency (POI), a condition where the ovaries stop working before age 40. The researchers will compare the genes of women with POI to those with normal ovarian function, which may lead to better understanding and future treatments.
Hear when a new Premature Ovarian Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.